RCA’s Perspective on the Latest AHA 340B Report

At Resource Corporation of America (RCA), we’ve spent over 30 years helping hospitals navigate the complexities of government programs. The 340B program has become a lifeline for safety-net hospitals and their patients. But lately, that lifeline has been under attack.

This week, the American Hospital Association (AHA) released a report that cuts through the noise and tells the truth: Hospitals are doing their part. Drug manufacturers, not so much.

Hospitals: Holding the Line Amid Heavy Scrutiny

According to the AHA’s findings, hospitals in the 340B program are facing the lion’s share of federal audits and passing with flying colors. The report shows a meaningful decline in issues like duplicate discounts and drug diversion from 2018 to 2022. That’s no accident. It reflects a real commitment from hospitals to strengthen internal audits, maintain compliance, and do right by the patients who depend on them.

Drug Manufacturers: Less Scrutiny, More Violations

On the other side of the table, drug companies are operating with far less federal oversight. Of the manufacturers audited, 60% had at least one adverse finding. Worse, most of those were required to repay 340B hospitals for overcharges.

It’s a frustrating pattern: manufacturers deflect blame onto hospitals while quietly breaking the rules.

Why This Matters to RCA and Our Hospital Partners

We work hand in hand with hospitals nationwide, especially those serving uninsured and underinsured populations. We see how vital 340B savings are to keeping clinics open, medications stocked, and care accessible.

That’s why we believe this report matters. It validates what hospitals have been saying: they operate with integrity. The report calls on lawmakers to hold manufacturers accountable.

What RCA Is Advocating For

We’re encouraging our partners and peers to:

  • Stay vocal: The 340B narrative needs to reflect reality. Hospitals are not the problem.
  • Support transparency: Drug pricing practices need the same level of scrutiny hospitals already face.
  • Protect what works: The 340B program is a critical tool in the fight for health equity. Weakening it helps no one, especially not the patients we’re all here to serve.

 

Final Thoughts

At RCA, we see the good work being done daily, and we know how hard it is to maintain compliance in the face of limited resources and constant regulation. This AHA report does not just vindicate hospitals; it reinforces the importance of fighting for fair oversight and sustainable solutions…because when hospitals are empowered to deliver care, everyone wins.